-
1
-
-
0021352277
-
Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments
-
Carrasquillo J.A., Krohn K.A., Beaumier P., McGuffin R.W., Brown J.P., Hellstrom K.E., et al. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat Rep 1984, 68:317-328.
-
(1984)
Cancer Treat Rep
, vol.68
, pp. 317-328
-
-
Carrasquillo, J.A.1
Krohn, K.A.2
Beaumier, P.3
McGuffin, R.W.4
Brown, J.P.5
Hellstrom, K.E.6
-
2
-
-
0029564367
-
Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma
-
Mulligan T., Carrasquillo J.A., Chung Y., Milenic D.E., Schlom J., Feuerstein I., et al. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma. Clin Cancer Res 1995, 1:1447-1454.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1447-1454
-
-
Mulligan, T.1
Carrasquillo, J.A.2
Chung, Y.3
Milenic, D.E.4
Schlom, J.5
Feuerstein, I.6
-
3
-
-
0028840870
-
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac
-
Waldmann T.A., White J.D., Carrasquillo J.A., Reynolds J.C., Paik C.H., Gansow O.A., et al. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood 1995, 86:4063-4075.
-
(1995)
Blood
, vol.86
, pp. 4063-4075
-
-
Waldmann, T.A.1
White, J.D.2
Carrasquillo, J.A.3
Reynolds, J.C.4
Paik, C.H.5
Gansow, O.A.6
-
6
-
-
0035478728
-
Pivotal study of iodine I-131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
-
Kaminski M.S., Zelenetz A.D., Press O.W., Saleh M., Leonard J., Fehrenbacher L., et al. Pivotal study of iodine I-131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol 2001, 19:3918-3928.
-
(2001)
J Clin Oncol
, vol.19
, pp. 3918-3928
-
-
Kaminski, M.S.1
Zelenetz, A.D.2
Press, O.W.3
Saleh, M.4
Leonard, J.5
Fehrenbacher, L.6
-
7
-
-
0037093241
-
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
-
Witzig T.E., Gordon L.I., Cabanillas F., Czuczman M.S., Emmanouilides C., Joyce R., et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 2002, 20:2453-2463.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2453-2463
-
-
Witzig, T.E.1
Gordon, L.I.2
Cabanillas, F.3
Czuczman, M.S.4
Emmanouilides, C.5
Joyce, R.6
-
9
-
-
0022515047
-
Chelating agents for the binding of metal ions to antibodies
-
Meares C.F. Chelating agents for the binding of metal ions to antibodies. Int J Rad Appl Instrum B 1986, 13:311-318.
-
(1986)
Int J Rad Appl Instrum B
, vol.13
, pp. 311-318
-
-
Meares, C.F.1
-
10
-
-
0024316503
-
Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity
-
Kozak R.W., Raubitschek A., Mirzadeh S., Brechbiel M.W., Junghans R.P., Gansow O.A., et al. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Cancer Res 1989, 49:2639-2644.
-
(1989)
Cancer Res
, vol.49
, pp. 2639-2644
-
-
Kozak, R.W.1
Raubitschek, A.2
Mirzadeh, S.3
Brechbiel, M.W.4
Junghans, R.P.5
Gansow, O.A.6
-
11
-
-
0025237122
-
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent
-
Deshpande S.V., DeNardo S.J., Kukis D.L., Moi M.K., McCall M.J., DeNardo G.L., et al. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med 1990, 31:473-479.
-
(1990)
J Nucl Med
, vol.31
, pp. 473-479
-
-
Deshpande, S.V.1
DeNardo, S.J.2
Kukis, D.L.3
Moi, M.K.4
McCall, M.J.5
DeNardo, G.L.6
-
13
-
-
0028279425
-
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies
-
Camera L., Kinuya S., Garmestani K., Wu C., Brechbiel M.W., Pai L.H., et al. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies. J Nucl Med 1994, 35:882-889.
-
(1994)
J Nucl Med
, vol.35
, pp. 882-889
-
-
Camera, L.1
Kinuya, S.2
Garmestani, K.3
Wu, C.4
Brechbiel, M.W.5
Pai, L.H.6
-
14
-
-
0029294701
-
Electrophoretic method for the quantitative determination of a benzyl-DTPA ligand in DTPA monoclonal antibody conjugates
-
Pham D.T., Kaspersen F.M., Bos E.S. Electrophoretic method for the quantitative determination of a benzyl-DTPA ligand in DTPA monoclonal antibody conjugates. Bioconjug Chem 1995, 6:313-315.
-
(1995)
Bioconjug Chem
, vol.6
, pp. 313-315
-
-
Pham, D.T.1
Kaspersen, F.M.2
Bos, E.S.3
-
15
-
-
0035083298
-
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA
-
Lewis M.R., Kao J.Y., Anderson A.L., Shively J.E., Raubitschek A. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. Bioconjug Chem 2001, 12:320-324.
-
(2001)
Bioconjug Chem
, vol.12
, pp. 320-324
-
-
Lewis, M.R.1
Kao, J.Y.2
Anderson, A.L.3
Shively, J.E.4
Raubitschek, A.5
-
16
-
-
0021026127
-
Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride
-
Paik C.H., Ebbert M.A., Murphy P.R., Lassman C.R., Reba R.C., Eckelman W.C., et al. Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. J Nucl Med 1983, 24:1158-1163.
-
(1983)
J Nucl Med
, vol.24
, pp. 1158-1163
-
-
Paik, C.H.1
Ebbert, M.A.2
Murphy, P.R.3
Lassman, C.R.4
Reba, R.C.5
Eckelman, W.C.6
-
17
-
-
0021067628
-
Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration
-
Paik C.H., Murphy P.R., Eckelman W.C., Volkert W.A., Reba R.C. Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration. J Nucl Med 1983, 24:932-936.
-
(1983)
J Nucl Med
, vol.24
, pp. 932-936
-
-
Paik, C.H.1
Murphy, P.R.2
Eckelman, W.C.3
Volkert, W.A.4
Reba, R.C.5
-
18
-
-
0028814493
-
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates
-
Kukis D.L., DeNardo G.L., DeNardo S.J., Mirick G.R., Miers L.A., Greiner D.P., et al. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res 1995, 55:878-884.
-
(1995)
Cancer Res
, vol.55
, pp. 878-884
-
-
Kukis, D.L.1
DeNardo, G.L.2
DeNardo, S.J.3
Mirick, G.R.4
Miers, L.A.5
Greiner, D.P.6
-
19
-
-
33749429154
-
177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties
-
177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties. Nucl Med Biol 2006, 33:883-889.
-
(2006)
Nucl Med Biol
, vol.33
, pp. 883-889
-
-
Knogler, K.1
Grunberg, J.2
Novak-Hofer, I.3
Zimmermann, K.4
Schubiger, P.A.5
-
20
-
-
0026503664
-
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium
-
Chang K., Pastan I., Willingham M.C. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. Int J Cancer 1992, 50:373-381.
-
(1992)
Int J Cancer
, vol.50
, pp. 373-381
-
-
Chang, K.1
Pastan, I.2
Willingham, M.C.3
-
21
-
-
0030069718
-
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers
-
Chang K., Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A 1996, 93:136-140.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 136-140
-
-
Chang, K.1
Pastan, I.2
-
22
-
-
37449006756
-
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
-
Hassan R., Ebel W., Routhier E.L., Patel R., Kline J.B., Zhang J., et al. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Cancer Immun 2007, 7:20.
-
(2007)
Cancer Immun
, vol.7
, pp. 20
-
-
Hassan, R.1
Ebel, W.2
Routhier, E.L.3
Patel, R.4
Kline, J.B.5
Zhang, J.6
-
23
-
-
78650339895
-
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin expressing cancers
-
Hassan R., Cohen S.J., Phillips M., Pastan I., Sharon E., Kelly R.J., et al. Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin expressing cancers. Clin Cancer Res 2010, 16:6132-6138.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 6132-6138
-
-
Hassan, R.1
Cohen, S.J.2
Phillips, M.3
Pastan, I.4
Sharon, E.5
Kelly, R.J.6
-
24
-
-
31544439933
-
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
-
Hassan R., Remaley A.T., Sampson M.L., Zhang J., Cox D.D., Pingpank J., et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006, 12:447-453.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 447-453
-
-
Hassan, R.1
Remaley, A.T.2
Sampson, M.L.3
Zhang, J.4
Cox, D.D.5
Pingpank, J.6
-
25
-
-
36749029362
-
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors
-
Zhang Y., Xiang L., Hassan R., Pastan I. Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors. Proc Natl Acad Sci USA 2007, 104:17099-17104.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 17099-17104
-
-
Zhang, Y.1
Xiang, L.2
Hassan, R.3
Pastan, I.4
-
26
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
27
-
-
0026889408
-
Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates
-
Pippin C.G., Parker T.A., McMurry T.J., Brechbiel M.W. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjug Chem 1992, 3:342-345.
-
(1992)
Bioconjug Chem
, vol.3
, pp. 342-345
-
-
Pippin, C.G.1
Parker, T.A.2
McMurry, T.J.3
Brechbiel, M.W.4
-
28
-
-
0022556055
-
Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling
-
Lindmo T., Bunn P.A. Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling. Methods Enzymol 1986, 121:678-691.
-
(1986)
Methods Enzymol
, vol.121
, pp. 678-691
-
-
Lindmo, T.1
Bunn, P.A.2
-
29
-
-
0033521739
-
111Indium labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin
-
111Indium labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin. Int J Cancer 1999, 80:559-563.
-
(1999)
Int J Cancer
, vol.80
, pp. 559-563
-
-
Hassan, R.1
Wu, C.2
Brechbiel, M.W.3
Margulies, I.4
Kreitman, R.J.5
Pastan, I.6
-
30
-
-
67349134673
-
A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution
-
Al-Ejeh F., Darby J.M., Thierry B., Brown M.P. A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution. Nucl Med Biol 2009, 36:395-402.
-
(2009)
Nucl Med Biol
, vol.36
, pp. 395-402
-
-
Al-Ejeh, F.1
Darby, J.M.2
Thierry, B.3
Brown, M.P.4
|